Chanelle Animal Health

Chanelle Pharma is Ireland's largest indigenous manufacturer of generic pharmaceutical products, serving both the human and animal health markets. Founded in 1985 and headquartered in Loughrea, the company specializes in the development, manufacturing, and distribution of complex generics, with a dominant presence in the veterinary sector. Its animal health portfolio includes market-leading anthelmintics, parasiticides, and pain management treatments exported to over 90 countries. The company operates state-of-the-art, FDA-approved manufacturing facilities and maintains a robust R&D program focused on generic product differentiation. In 2024, Chanelle Pharma was acquired by the private equity firm Exponent to accelerate its international expansion and product pipeline development.